Could Patients with Breast Cancer Safely Skip Radiation & the Potential Side Effects? Inside the ROSALIE Clinical Trial

Could skipping radiation after breast-conserving surgery be safe for some patients? The ROSALIE trial is exploring this possibility. In this episode, we sit down with Professor Boon Chua, Radiation Oncologist and Professor of Medicine at the University of New South Wales, who leads the Breast Cancer Trials ROSALIE clinical trial.

Professor Chua discusses how the study aims to de-escalate treatment for women with early-stage breast cancer who achieve a complete response to chemotherapy, potentially reducing side effects without compromising outcomes.

• (2:06) What is the ROSALIE clinical trial hoping to find out?
• (2:51) How could this research change the way we treat breast cancer in the future, especially for patients with early-stage disease?
• (3:30) What would you like patients and the public to understand about the importance of participating in trials like this?

Tune in for a deep dive into this important research.

⁠⁠⁠⁠Donate to Support Life-Saving Research⁠⁠⁠⁠

Like this episode? ⁠⁠⁠⁠Find more Breast Cancer Trials Podcast Episodes here⁠⁠⁠⁠

Follow Breast Cancer Trials on Social Media:

• Instagram:⁠ ⁠⁠⁠@breastcancertrials⁠⁠⁠⁠
• Facebook:⁠ ⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠
• LinkedIn: ⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠
• X: ⁠⁠⁠⁠@BCTrialsANZ⁠⁠⁠⁠

Guest: Medical Oncologist, Dr Boon Chua.

Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about the importance of clinical trials research.